Statin Rebound or Withdrawal Syndrome: Does It Exist?
- 506 Downloads
Studies in vascular cells in culture and in laboratory animals revealed that statin discontinuation triggers a rebound deterioration of vascular function. Retrospective studies of patients admitted with an acute coronary syndrome revealed that stopping statins during the first days of admission was associated with worse outcomes. In a prospective, randomized controlled trial in patients with a hemispheric ischemic stroke, stopping statins for 3 days was associated with a 4.7-fold increase in the risk of death or dependency, greater neurological deterioration, and a larger infarct volume. Discontinuing statins during the post-operative period following major vascular surgery was associated with a higher incidence of myocardial ischemia, nonfatal myocardial infarction, and cardiovascular death. However, no increase in adverse outcomes was observed in patients with stable chronic coronary artery disease following statin treatment discontinuation. Despite some study limitations, the bulk of the evidence suggests that under conditions of severe acute vascular stress, removal of statins must be contraindicated.
KeywordsStatins Statin withdrawal Acute coronary events Acute ischemic stroke Major vascular surgery
Andres Pineda reports no potential conflict of interest relevant to this article. Luigi Cubeddu reports no potential conflict of interest relevant to this article.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 3.Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2002; 285:2486-2497.Google Scholar
- 7.SSSS Investigators. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet.1994; 344:1383–1389.Google Scholar
- 11.• Feher A, Pusch G, Koltai K, et al. Statin therapy in the primary and the secondary prevention of ischaemic cerebrovascular diseases. Int J Cardiol 2010 Sep 14. [Epub ahead of print]. This article discusses the benefits of statin therapy in primary and secondary prevention of stroke.Google Scholar
- 33.• Risselada R, Straatman H, van Kooten F, et al. Withdrawal of statins and risk of subarachnoid hemorrhage. Stroke 2009; 40:2887–2892. This article shows that recent withdrawal of statin therapy (< 30days) is associated with increased risk of developing a subarachnoid hemorrhage.CrossRefPubMedGoogle Scholar
- 35.Wassmann S, Laufs U, Baumer AT, Muller K, Konkol C, Sauer H, Bohm M and Nickenig G. Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase. Mol Pharmacol 2001;59(3): 646–654.PubMedGoogle Scholar